Human Cannabinoid Pharmacokinetics

Cited by (1,000)

Items 701–800 of 1,000

1. Exploring the Potential of Nonpsychoactive Cannabinoids in the Development of Materials for Biomedical and Sports Applications
   Dulexy Solano-Orrala, Dennis A. Silva-Cullishpuma, Eliana Díaz-Cruces, Vicente M. Gómez‐López, Jhoan Toro‐Mendoza, Giovanna Gomez d’Ayala, Jorge Troconis, Christian Narváez‐Muñoz, Frank Alexis, María Teresa Mercader‐Ros et al. · 2024 · ACS Applied Bio Materials
2. Mechanisms and strategic prospects of cannabinoids use: Potential applications in antimicrobial food packaging—A review
   Moumita Dey, Sharmita Bera, Preeti Tyagi, Lokendra Pal · 2025 · Comprehensive Reviews in Food Science and Food Safety
3. Cannabis: Zone Aspects of Raw Plant Components in Sport—A Narrative Review
   Corina Flangea, Mihaela Vlad, Roxana Popescu, Victor Dumitraşcu, Andreea Luciana Rață, Maria Erika Tryfon, Bogdan Balasoiu, Cristian Sebastian Vlad · 2025 · Nutrients
4. Synthetic cannabinoids : general considerations
   Nik De Brabanter, Koen Deventer, Veronique V. Stove, Peter Van Eenoo · 2013 · Ghent University Academic Bibliography (Ghent University)
5. PBPK modeling characterization of potential acute impairment effects from inhalation of ethanol during e-cigarette use
   Sharlee L. More, Stephanie A. Thornton, Joshua R. Maskrey, Apurva Sharma, Elise de Gandiaga, Thales J. Cheng, Ernest S. Fung, Autumn J. Bernal, Amy K. Madl · 2020 · Inhalation Toxicology
6. Analysis of cannabinoids in plants, marijuana products and biological tissues
   Markel San Nicolás, Aitor Villate, Mara Gallastegi, Oier Aizpurua‐Olaizola, Maitane Olivares, Néstor Etxebarría, Aresatz Usobiaga · 2020 · Comprehensive analytical chemistry
7. The positive and negative cardiovascular effects of cannabis
   Mitchell Brady Adamson, Bennett Di Giovanni, Diego Delgado · 2020 · Expert Review of Cardiovascular Therapy
8. Use of a water-soluble form of cannabinol for the treatment of sleeplessness
   Robert Kaufmann · 2021 · International Journal of Complementary & Alternative Medicine
9. Distribution of tetrahydrocannabinol and cannabidiol in several different postmortem matrices
   Siren Pettersen, Åse Marit Leere Øiestad, Sidsel Rogde, Gerd‐Wenche Brochmann, Elisabeth Leere Øiestad, Vigdis Vindenes · 2021 · Forensic Science International
10. Drug-Drug Interaction Between Orally Administered Hydrocodone-Acetaminophen and Inhalation of Cannabis Smoke: A Case Report
    Ross Jason Bindler, Christy J.W. Watson, Abram J. Lyons, Lillian Skeiky, J. Lewis, Michael G. McDonell, Philip J. Lazarus, Marian Wilson · 2021 · Hospital Pharmacy
11. The Relationship Between Plasma Tetrahydrocannabinol Levels and Intraocular Pressure in Healthy Adult Subjects
    Sameh Mosaed, Andrew K. Smith, John H.K. Liu, Donald S. Minckler, Robert L. Fitzgerald, David J. Grelotti, Emily G. Sones, Robert Neal Weinreb, Thomas D. Marcotte · 2022 · Frontiers in Medicine
12. Substance abuse and male sexual dysfunction: what lies beneath?
    Taymour Mostafa, Moheiddin Fakhry Alghobary · 2023 · Sexual Medicine Reviews
13. Cannabis and Pain Control After Total Hip and Knee Arthroplasty
    Babar Kayani, Lisa C. Howard, Michael E. Neufeld, Donald S. Garbuz, Bassam A. Masri · 2023 · Orthopedic Clinics of North America
14. A single-center real-life study on the use of medical cannabis in patients with dystonia
    Saar Anis, Achinoam Faust‐Socher, Diana Sverdlov, Simon Lassman, Neomi Hezi, Omer Anis, Gil Leor, Amos D. Korczyn, Nir Giladi, Tanya Gurevich · 2023 · Frontiers in Neurology
15. Effects of concomitant use of THC and irinotecan on tumour growth and biochemical markers in a syngeneic mouse model of colon cancer
    Suzana Žunec, Irena Brčić Karačonji, Martin Čatalinac, Andreja Jurič, Anja Katić, Goran Kozina, Vedran Micek, Marijana Neuberg, Ana Lucić Vrdoljak · 2023 · Archives of Industrial Hygiene and Toxicology
16. Supporting gut health with medicinal cannabis in people with advanced cancer: potential benefits and challenges
    Hannah R. Wardill, Luke T. Wooley, Olivia M. Bellas, Katrina Cao, Courtney Cross, Madelé van Dyk, Ganessan Kichenadasse, Joanne M. Bowen, Andrew C.W. Zannettino, Sepehr Shakib et al. · 2023 · British Journal of Cancer
17. Assessment of oxidative stress of platelets among chronic heroin and hashish addicts
    Mohammad Bani-Ahmad, Ayman Mustafa, AAB Ahmad, AMA Rahim · 2018 · Human & Experimental Toxicology
18. Human Laboratory Models of Cannabis Use Disorder
    Caroline A. Arout, Evan Sullivan Herrmann, Margaret Haney · 2018 · Springer eBooks
19. Cannabis-Impaired Driving: Evidence and the Role of Toxicology Testing
    Ed Wood, Robert L. DuPont · 2020 · Springer eBooks
20. Cannabinoids-based Medicine Pharmacology, Drug Interactions, and Perioperative Management of Surgical Patients
    Samer Narouze, Natalie H. Strand, Priodarshi Roychoudhury · 2020 · Advances in Anesthesia
21. Pharmacology and Mechanism of Action of Drugs
    Michelle Groves Carlin · 2022 · Elsevier eBooks
22. Design Considerations for Medicinal Cannabis Clinical Trials in People Receiving Palliative Care
    Valentina Razmovski‐Naumovski, Jennifer H. Martin, Richard Chye, Jane Louise Phillips, Nicholas Lintzeris, Nadia Solowij, Jessica Tsuann Lee, Melanie R Lovell, Bev Noble, Peter Galettis et al. · 2025 · Journal of Pain and Symptom Management
23. Literature review on forensic implications of illicit drug metabolism: A medicinal chemistry perspective
    Pawan Mandal, Jitesh Kumar, Debasis Bora, Syed Ahmar Ali Hashmi, Mohit Tiwari, Ritu Gupta, Amit Kumar Behera, Miss Amoli, Jaydeep Singh, Sudhanshu Kumar Jha · 2026 · Journal of Forensic and Legal Medicine
24. The impact of pregnancy and associated hormones on the pharmacokinetics of Δ 9 -tetrahydrocannabinol
    Aurora K. Authement, Nina Isoherranen · 2024 · Expert Opinion on Drug Metabolism & Toxicology
25. Comparative Pharmacokinetic Assessment of Innovative Sublingual, Rectal and Vaporizer Cannabis Products Versus Approved Cannabis Products in Healthy Volunteers
    Sheina Tarlovski, Anat Bar Kadmon, Eran Goldberg, Dadi Segal, Dov Gavish, David Stepensky · 2024 · Cannabis and Cannabinoid Research
26. Cannabinoids for treating psychiatric disorders in youth: a systematic review of randomized controlled trials
    Patrick Köck, Andrzej Badek, Maximilian Meyer, Arndt-Lukas Klaassen, Marc Walter, Jochen Kindler · 2024 · Child and Adolescent Psychiatry and Mental Health
27. In vitro exposure of whole blood to a cannabinoid mixture impairs the quality of red blood cells and platelets.
    Marie-Claude Lampron, Clémence Desbiens-Tremblay, Lionel Loubaki · 2023 · PubMed Central
28. Effects of cannabinoid agonists and antagonists in male rats discriminating the synthetic cannabinoid AM2201
    Dalal Ahmed Alkhelb, Emily L. Burke, Alexander M. Zvonok, Christos Iliopoulos‐Tsoutsouvas, Markos‐Orestis Georgiadis, Shan Hao Jiang, Thanh C. Ho, Spyros P. Nikas, Alexandros Makriyannis, Rajeev I. Desai · 2023 · European Journal of Pharmacology
29. Acute and chronic cannabis vapor exposure influences basal and stress-induced release of glucocorticoids in male and female rats
    Savannah H. M. Lightfoot, Samantha L. Baglot, Catherine Hume, Laine M. Grace, Ryan J. McLaughlin, Matthew N. Hill · 2024 · Psychoneuroendocrinology
30. Prolonged sedation and unconsciousness after intoxication with the novel semisynthetic cannabinoid hexahydrocannabioctyl (HHC-C8): Two case descriptions
    Ragnar Thomsen, Tobias Melton Axelsen, Nicoline Løkken, Lisa Maria Gemmerli Krogh, Nanna Reiter, Brian Schou Rasmussen, Emilie Lund Laursen · 2025 · Toxicology Reports
31. Lifetime Average Cannabis Use in Relation to Hypertriglyceridemic Waist Phenotype in U.S. Adults: A Population-Based Cross-Sectional Study
    Gérard Ngueta · 2020 · Cannabis and Cannabinoid Research
32. Quantitating cannabinoids in edible chocolates using heated ultrasonic-assisted extraction
    James W. Favell, Ryan Hayward, Emily O'Brien, Seamus Riordan-Short, N. R. V. Sagar, Rob O’Brien, Matthew R. Noestheden · 2020 · Comprehensive analytical chemistry
33. Cerebrovascular Complications Associated with Marijuana Use
    Bayan Moustafa, Fernando Daniel Testai · 2021 · Current Neurology and Neuroscience Reports
34. Long-Term Frequent Cannabis Use and Related Serum Cannabinoid Levels Are Not Associated with Kidney Dysfunction
    Udo Bonnet, Thorsten Borda, Norbert Scherbaum, Michael Specka · 2021 · Cannabis and Cannabinoid Research
35. Sample entropy discriminates balance performance of older cannabis users from non-users
    Craig David Workman, Jacob J. Sosnoff, Thorsten Rudroff · 2022 · Clinical Biomechanics
36. A Review on the Impact of Cannabis in Society and the Analytical Methodologies for Cannabinoids
    Matthew J. Vergne, Lindsey J. Reynolds, Alexus Brown, Grayson Pullias, Anna Froemming · 2023 · Psychoactives
37. Pediatric Dosing Considerations for Medical Cannabis
    Jane Alcorn, Stephanie Vuong, Fang Ping Wu, Blair W. Seifert, Andrew William Lyon · 2019 · IntechOpen eBooks
38. Cannabinoids, hippocampal excitability and efficacy for the treatment of epilepsy
    Isaac Yao, Efrat Shavit Stein, Nicola Maggio · 2019 · Pharmacology & Therapeutics
39. Where Are We and Where Are We Going?
    Leslie Lars Iversen · 2018 · Oxford University Press eBooks
40. Effect of cannabidiol and hemp extract on viability and function of hepatocytes derived from human induced pluripotent stem cells
    Kayla Campasino, Miranda R. Yourick, Yang Zhao, Estatira Sepehr, Cory A. Vaught, Jeffrey J. Yourick, Robert L. Sprando, Xiugong Gao · 2024 · Toxicology in Vitro
41. Pharmacokinetics of Cannabidiol in Rat Brain Tissue After Single-Dose Administration of Different Formulations
    Zuzana Bínová, František Beneš, Marie Zlechovcová, Matěj Malý, Petr Kaštánek, Monika Cahová, Milena Stranska-Zachariasova, Jana Hajšlová · 2025 · Molecules
42. Cannabis use is associated with changes in psychological and functional well-being during young adulthood: evidence from self-reports and hair analyses
    Lydia Johnson‐Ferguson, Michelle Loher, Laura Bechtiger, Clarissa Janousch, Markus R. Baumgartner, Tina M. Binz, Denis Ribeaud, Manuel Eisner, Boris B. Quednow, Lilly Shanahan · 2025 · Psychological Medicine
43. Differentiation of Therapeutic and Illicit Drug Use via Metabolite Profiling
    Stanila Stoeva, Nadezhda Hvarchanova, Silvia Gancheva, Miroslav Eftimov, Kaloyan Georgiev, Maya P. Radeva-Ilieva · 2025 · Metabolites
44. Cannabinol for Acute Treatment of Insomnia Disorder in a Randomized Placebo‐Controlled Crossover Trial
    Isobel Lavender, Nathaniel S. Marshall, Danielle McCartney, Garry Cho, Christopher G. Irwin, Anastasia S. Suraev, Rebecca Gordon, Jonathon Carl Arnold, Angela L. D'Rozario, Christopher J. Gordon et al. · 2026 · Journal of Sleep Research
45. Cannabis Science and Therapeutics: An Overview for Clinicians
    Leah Sera, Carrie Hempel-Sanderoff · 2023 · Journal of clinical pharmacology
46. Characterizing the Cannabis Withdrawal Trajectory in Men With Cannabis and Tobacco Co-Use: A Preliminary Study
    Zac J.S. Yeap, Lyne Baaj, Tony Peter George, Romina Mizrahi, Rachel Allison Rabin · 2024 · The Canadian Journal of Addiction
47. Association of driving with blood delta-9-tetrahydrocannabinol: a systematic review
    Danial Behzad, Sampson Zhao, Reena Besa, Bruna Brands, Christine M. Wickens, Marilyn Ann Huestis, Bernard Le Foll, Patricia Di Ciano · 2025 · The International Journal of Neuropsychopharmacology
48. Analysis of cannabinoids and semi-synthetic cannabinoids in authentic breastmilk samples by liquid chromatography–tandem mass spectrometry
    Marco Ballotari, Michael T Truver, Nayana A Sojin, Rhea Parimoo, Lauren A Agliano, Jennifer L Hoyer, Amie J. Goodin, Deepthi Satheesa Varma, Chris W. Chronister, Kay Roussos-Ross et al. · 2025 · Journal of Analytical Toxicology
49. Cannabis tolerance reduces symptom relief
    Sarah See Stith, Xiaoxue Li, Franco Brockelman, Keenan Keeling, Branden Hall, Jacob Miguel Vigil · 2025 · Frontiers in Pharmacology
50. UGT2B7-mediated drug–drug interaction between cannabinoids and hydromorphone
    Shelby Coates, Keti Bardhi, Mengqi Zhao, Philip J. Lazarus · 2025 · Drug Metabolism and Disposition
51. Evidence on the effect of in-utero cannabis exposure in neonates
    Basel Thayyil, Kamran Yusuf · 2025 · Journal of Perinatology
52. Cannabis und Cannabinoide zur Therapie akuter und chronischer Schmerzen
    Michael Schäfer, Sascha Tafelski · 2021 · Der Anaesthesist
53. Perceptions on acceptability and reported consumption of marijuana by blood donors prior to donation in the recreational use state of Colorado, USA
    Kyle Annen, Melkon G. DomBourian · 2021 · Vox Sanguinis
54. Therapeutic use of cannabis in the US
    Tracy Klein, Carey S. Clark · 2022 · The Nurse Practitioner
55. Cannabis and regulatory science: A review of challenges in Africa
    Norman Zimunda Nyazema · 2023 · African Journal of Pharmacy and Pharmacology
56. Acute and chronic impact of cannabis on human cognition
    Justin Matheson, Bernard Le Foll · 2023 · Elsevier eBooks
57. Dose-dependent Relationships of Same-day and Typical Substance Use to Sleep Duration in College Cannabis and Alcohol Users: A Multilevel Modeling Approach Using Daily Diary Data
    Neel Muzumdar, Kristina M. Jackson, Jennifer F. Buckman, Andrea M. Spaeth, Alexander W. Sokolovsky, Anthony P. Pawlak, HELENE RASKIN WHITE · 2023 · Cannabis
58. Effect of vaporizing cannabis rich in cannabidiol on cannabinoid levels in blood and on driving ability – a randomized clinical trial
    Laura Egloff, Priska Frei, Kathrin Gerlach, Katja Mercer‐Chalmers‐Bender, Eva Scheurer · 2023 · International Journal of Legal Medicine
59. Adverse effects of delta‐9‐tetrahydrocannabinol on sickle red blood cells
    Aline Hatem, Sofia Esperti, Nicoletta Murciano, Min Qiao, Maria Giustina Rotordam, Nadine Becker, Élie Nader, Felix Maurer, Laurent Pérès, Guillaume Bouyer et al. · 2023 · American Journal of Hematology
60. Analytical techniques for screening of cannabis and derivatives from human hair specimens.
    R. Kale, D. Chaturvedi, P. Dandekar, R. Jain · 2024 · Analytical Methods
61. Tolerability of High-Dose Oral Δ 9 -THC: Implications for Human Laboratory Study Design
    Jan Rožanc, Linda E. Klumpers, Marilyn Ann Huestis, Michael Tagen · 2024 · Cannabis and Cannabinoid Research
62. Understanding the Potential of CBD for Health Benefits: An Overview
    I. A. T. Santos, M. Beatriz P.P. Oliveira, Ana Casas, Javier Fidalgo, Hugo Almeida · 2024 · Current Drug Discovery Technologies
63. Biodegradable cannabidiol: a potential nanotherapeutic for neuropathic pain
    Sana Qayum, Rebecca R. Schmitt, Janvhi Suresh Machhar, Sonali Garg, Caroline E. Bass, Vijaya Prakash Krishnan Muthaiah, Tracey A. Ignatowski, Supriya D. Mahajan · 2024 · NeuroImmune Pharmacology and Therapeutics
64. Pharmacokinetics and Side Effects of Δ9-Tetrahydrocannabinol and Cannabidiol in Patients with Different Stages of CKD
    Marie Bach Sønderskov, Dinah Sherzad Khatir, Krista Dybtved Kjærgaard, Jørgen Bo Hasselstrøm, Lambert K. Sørensen, Eva Aggerholm Sædder, Charlotte Uggerhøj Andersen · 2024 · Kidney International Reports
65. Brief exposure to (-) THC affects zebrafish embryonic locomotion with effects that persist into the next generation
    Md Ruhul Amin, Lakhan S. Khara, Joshua Szaszkiewicz, A. Kim, Trevor J. Hamilton, Declan W. Ali · 2025 · Scientific Reports
66. ∆9-Tetrahydrocannabinol Increases Growth Factor Release by Cultured Adipose Stem Cells and Adipose Tissue in vivo
    Tim Ruhl, Sofija Benic, Melissa Plum, Bong‐Sung Kim, Justus P. Beier, Benedikt Schäfer · 2025 · Tissue Engineering and Regenerative Medicine
67. Hippocampal apoptosis: Molecular mechanisms triggered by toxic cannabinoid exposure: A narrative review
    Habibeh Mashayekhi‐Sardoo, Mahdiyeh Hedayati‐Moghadam, Yousef Baghcheghi · 2025 · NeuroToxicology
68. GC–MS as a valuable tool for analysing cannabinoid-containing gummies and identifying the synthetic process used for their production
    Arianna Bini, E. Roda, Stefano Protti, Luca Morini, Antonella Profumo, Marco Cavallo, Adolfo Gregori, C. Locatelli, Daniele Merli · 2025 · Forensic Chemistry
69. Impact of prenatal delta-9-tetrahydrocannabinol exposure on mouse brain development: a fetal-to-adulthood magnetic resonance imaging study
    Lani Cupo, Haley A. Vecchiarelli, Daniel Gallino, Jared VanderZwaag, Katerina Bradshaw, Annie Phan, Mohammadparsa Khakpour, Benneth Ben‐Azu, Elisa Guma, Jérémie P. Fouquet et al. · 2025 · Molecular Psychiatry
70. Pharmacokinetics and pharmacodynamics of drugs abused in driving
    Marilyn Ann Huestis, Michael L. Smith · 2009 · Birkhäuser Basel eBooks
71. Cannabis use history is associated with increased prevalence of ascites among patients with nonalcoholic fatty liver disease: A nationwide analysis
    Catherine J Choi, Stanley H. Weiss, Umair M. Nasir, Nikolaos Pyrsopoulos · 2020 · World Journal of Hepatology
72. The Physiological Effects, Including Risks and Potential Benefits, of Cannabis for Patients Undergoing Elective Orthopedic Procedures
    Rachel C. Talley-Bruns, Michael S. Shatkin, Yasmin Dhar, Steven B. Zelicof · 2021 · Orthopedics
73. Physiologically-based pharmacokinetic model for predicting blood and tissue tetrahydrocannabinol concentrations
    Leo Zhu, William Pei, Patricia Di Ciano, Bruna Brands, Christine M. Wickens, Bernard Le Foll, Bronsen Kwong, Megha Parashar, Atchu Sivananthan, Radhakrishnan Mahadevan · 2021 · Computers & Chemical Engineering
74. Cannabinoide zur Therapie chronischer Nervenschmerzen und Spastik
    Matthias Karst · 2022 · MMW - Fortschritte der Medizin
75. An overview of liquid chromatographic methods for analyzing new generation anti-epileptic drugs
    Mohammed ALSaeedy, Ahmed Hasan, Arwa Al-Adhreai, Ali Alrabie, Hafsah Qaba, Abdulrahman Mashrah, Elif Mine Öncü-Kaya · 2022 · Journal of Liquid Chromatography & Related Technologies
76. Propylene glycol and Kolliphor as solvents for systemic delivery of cannabinoids via intraperitoneal and subcutaneous routes in preclinical studies: a comparative technical note
    Kaveh Momenzadeh, Diana Yeritsyan, Nadim Kheir, Rosalynn M. Nazarian, Ara Nazarian · 2023 · Journal of Cannabis Research
77. Human Data on Pharmacokinetic Interactions of Cannabinoids: A Narrative Review
    Cecilia Maldonado, Raquel Peyraube, Pietro L. Fagiolino, Florencia Oricchio, Leticia Cuñetti, Marta Vázquez · 2024 · Current Pharmaceutical Design
78. Cannabinoid levels description in a cohort of patients with chronic and neuropathic pain treated with Cannabis decoction: A possible role of TDM
    Alessandra Manca, Cristina Valz, Francesco Chiara, Jacopo Mula, Alice Palermiti, Martina Billi, Miriam Antonucci, Amedeo De Nicolò, Nicola Luxardo, Daniele Imperiale et al. · 2024 · Biomedicine & Pharmacotherapy
79. Illicit drugs in wastewater treatment plants utilization of wastewater-based epidemiology in a Brazilian regional city
    Ferreira Aldo Pacheco · 2020 · World Journal of Advanced Research and Reviews
80. Phytocannabinoids: Tetrahydrocannabinol (THC)
    Priodarshi Roychoudhury, Ning Nan Wang, Samer Narouze · 2021 · Springer eBooks
81. A Phase I Trial to Determine the Pharmacokinetics, Psychotropic Effects, and Safety Profile of a Novel Nanoparticle-Based Cannabinoid Spray for Oromucosal Delivery
    Stefan Lorenzl, Franz Gottwald, Angelika Nistler, Laura Brehm, Renate Grötsch, Georg Haber, Christian Bremm, Christiane Eva Weck, Carina Trummer, Werner Brand · 2022 · Medical Cannabis and Cannabinoids
82. Toward a Comprehensive Model of ∆9-Tetrahydrocannabinol Pharmacokinetics Using a Population Pharmacokinetics Approach
    Brett C. Ginsburg · 2014 · Clinical Pharmacokinetics
83. Medical Use of Marijuana
    Mohamed Naguib, Joseph F. Foss · 2015 · Anesthesia & Analgesia
84. A Pediatric Hospital Policy for Medical Marijuana Use
    Amy E. Carver, Jennifer E. Jorgensen, Michael Barberio, Carla E. Lomuscio, David E. Brumbaugh · 2020 · PEDIATRICS
85. The Effects of Acute Δ9-Tetrahydrocannabinol on Striatal Glutamatergic Function: A Proton Magnetic Resonance Spectroscopy Study
    Michael Bloomfield, Kat Petrilli, Rachel Lees, Chandni Hindocha, Katherine Beck, Ryan J. Turner, Ellis Chika Onwordi, Neil Rane, David J. Lythgoe, James M. Stone et al. · 2021 · Biological Psychiatry Cognitive Neuroscience and Neuroimaging
86. Recreational Drugs: Effects on the Heart and Cardiovascular System
    Benjamin Starobin, Soumyajit Jablonski, A.M. Andrle, J.B. Powers · 2017 · Elsevier eBooks
87. Cannabinoid-Based Medicines: Dosing, Titration & Monitoring
    MacCallum, Caroline A., de Freitas, Lauren, Lo, Lindsay A., Boivin, Michael · 2021 · Cannabinoids and Pain
88. Development and validation of a method for analysis of 25 cannabinoids in oral fluid and exhaled breath condensate
    Meena Swaminathan, Anamary Tarifa, Anthony P. DeCaprio · 2024 · Analytical and Bioanalytical Chemistry
89. Evaluating Vaporized Cannabinoid Therapy in Multiple Sclerosis: Findings from a Prospective Single-Center Clinical Study
    Konstantina Stavrogianni, Dimitrios K. Kitsos, Vasileios Giannopapas, Vassiliki Smyrni, Athanasios K. Chasiotis, Alexandra Akrivaki, Evangelia Makrina Dimitriadou, Christina Zompola, John S. Tzartos, Georgios K. Tsivgoulis et al. · 2025 · Journal of Clinical Medicine
90. Infant Death due to Cannabis Ingestion
    Donata Favretto, Antonello Cirnelli, Roberto Pértile, Raffaella Stimamiglio, Clara Cestonaro, Oriana Cuman, Anna Pagliaro, Fabio Mattiazzi, Cristina Basso, Maddalena Galeazzi · 2025 · Drug Testing and Analysis
91. The detection of cannabinoids in breath after ingestion of cannabis-infused edibles
    Jennifer L. Berry, Ashley Brooks‐Russell, Tara M. Lovestead, Kavita M. Jeerage · 2025 · Journal of Analytical Toxicology
92. Human diagnostic markers for intake of semi-synthetic cannabinoids (9R)- and (9S)-hexahydrocannabinol
    Prince Sellase Gameli, Omayema Taoussi, Annagiulia Di Trana, L Tronconi, Simona Pichini, Jeremy Carlier, Marilyn Ann Huestis, Francesco Paolo Busardò · 2025 · Clinica Chimica Acta
93. Analysis of six CYP450 genetic variants regarding the response to cannabidiol combined with anticonvulsant medication in mexican patients with drug-resistant epilepsy
    Iris Angélica Feria-Romero, Luísa Rocha, Araceli Reyes-Cuayahuitl, Iris Enriqueta Martínez-Juárez, Daniel San‐Juan, Consuelo Escamilla-Núñez, Sandra Adela Orozco-Suárez · 2025 · Frontiers in Pharmacology
94. Bio-based pectin films with cannabidiol extract from pollen of Cannabis sativa L - active packaging to protect anthocyanins in Thomson seedless dark grapes
    Renata Dobrucka, Marcin Szymański · 2025 · Colloids and Surfaces B Biointerfaces
95. Uncovering contextual risk patterns in cannabis-involved fatal crashes: A data-driven approach to public health-oriented road safety
    Rohit Chakraborty, Sazzad Bin Bashar Polock, Biplov Pandey, Sawgat Ahmed Shuvo, Kakan Chandra Dey, Subasish Das · 2025 · Journal of Safety Research
96. Therapeutic use of cannabinoids in age-related pain: Current evidence and clinical perspectives
    Sabina Pulone, Chantalle Moulton, Saverio Nucera, Sara Ilari, Carolina Muscoli, Ennio Tasciotti · 2026 · Pharmacological Research
97. Perception and Belief on Cannabinoids: A Comparative Study of Rheumatology Patients and Primary Care Physicians on the Use of Cannabinoids for Pain Management
    Nibha Jain, Neelima Reddy Kunam, Arumugam Moorthy · 2021 · Cureus
98. Nabiximols effect on blood pressure and heart rate in post-stroke patients of a randomized controlled study
    Gian Marco Rosa, Luca Puce, Laura Mori, Antonio Currà, Francesco Fattapposta, Italo Porto, Nicola Luigi Bragazzi, Carlo Trompetto, Lucio Marinelli · 2022 · Frontiers in Cardiovascular Medicine
99. Cannabidiol in urine is not a proof of CBD consumption—lesson learned from urine sample analysis in routine caseworks
    Marine Deville, Corinne Charlier · 2022 · Forensic Toxicology
100. Cannabis, cannabinoids, and receptor responses
     Yi Yang, Roya Derwish, Lakshmi P. Kotra · 2023 · Elsevier eBooks